
Corporate venture fund of the Dentsu Group that backs startups with capital and hands-on business support

Life sciences company builder that identifies, incubates and grows healthcare ventures in China and globally

Quan Capital is a firm that builds companies in life sciences. It says it finds, incubates and grows future industry players, following healthcare trends and new medical advances.
Biotechnology and pharmaceutical companies. Its news feed reports on portfolio firms such as Syros, Kira Pharmaceuticals and Arcellx, covering regulatory designations, clinical trial clearances and partnerships.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-09. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Quan Capital.
Similar listings buyers compare against this one.

Corporate venture fund of the Dentsu Group that backs startups with capital and hands-on business support

Investment fund backing women-led small businesses in Sénégal and Côte d'Ivoire with capital and support

Venture investor backing enterprise software founders, led by people who have built companies themselves

An Israeli investment and technology-transfer platform connecting international investors with the country's startup ecosystem

Corporate-backed investor that funded emerging energy technology companies across renewables, grid and fossil fuel sectors

Chinese asset manager offering investment solutions across China-related assets for institutional clients
Everything here links back to the same verified catalogue. Pick your next stop.